Metraipolis › archive › dc_f775487b617d

Dosimetry in 177Lu-PRRT for Neuroendocrine Tumors: Current Concepts, Clinical Relevance and Future Perspectives — Europe PMC PMID:42452414

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42452414
DOI
10.3390/jcm15134952
License (as archived)
solo-consultazione
Archived
2026-10-19T02:27:24.958Z
SHA-256 of the archived text
f860e46d8c209af0633baf0425f65c70cfed08ebe917c8400ead2ebacd9f0e3c
Stable URL of this page
https://metraipolis.com/documento/dc_f775487b617d

How to cite

Dosimetry in 177Lu-PRRT for Neuroendocrine Tumors: Current Concepts, Clinical Relevance and Future Perspectives — Europe PMC PMID:42452414 — Europe PMC (en), https://europepmc.org/article/MED/42452414 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f775487b617d (Metraipolis archive dc_f775487b617d, sha256 f860e46d8c209af0633baf0425f65c70cfed08ebe917c8400ead2ebacd9f0e3c)
BibTeX
@misc{dcf775487b617d,
  title = {Dosimetry in 177Lu-PRRT for Neuroendocrine Tumors: Current Concepts, Clinical Relevance and Future Perspectives — Europe PMC PMID:42452414},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42452414},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f775487b617d; sha256 f860e46d8c209af0633baf0425f65c70cfed08ebe917c8400ead2ebacd9f0e3c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42452414. Agents can read the archived copy with the MCP tool read_document.